Calcium (Ca2+) drives many cellular functions, though the way it controls quality of proteins in the endoplasmic reticulum ...

California will cap insulin co-pays at $35 and launch CalRx state-branded insulin in 2026 under new legislation signed by ...

SaveHealth reports on managing type 2 diabetes through medications, lifestyle changes, and support, highlighting various ...

Cipla had received regulatory approval from the Central Drugs Standard Control Organisation late last year for the exclusive ...

Drugmaker Cipla has launched Afrezza (insulin human) inhalation powder, the company said, about a year after the product got ...

More than a million Americans with diabetes may be skipping insulin doses or delaying purchase of the drug because of its expense, said authors of a new study. Based on data from 982 insulin users ...

This article was reviewed by Felix Gussone, MD. Key Takeaways: Hormones like insulin, cortisol, thyroid hormones, and ...

Philadelphia has filed a lawsuit against several major drug manufacturers and pharmacy benefit managers, accusing them of ...

Insulin prices have risen steadily since the 1990s. In fact, between 2012 and 2016, the cost of insulin increased by 20.7 percent every year. Increases have been slower in recent years, but costs are ...

The new CalRx insulin will hit the market in January at $55 a month, part of a broader state effort to rein in drug costs.

Fathers exposed to microplastics before conception may be setting their daughters up for metabolic problems later in life.

About 14% of adults in Philadelphia have diabetes, one of the highest rates in the country, the city said, and Black and ...